Review



s1 subunit vaccine strain omicron variant spike proteins  (GenScript corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenScript corporation s1 subunit vaccine strain omicron variant spike proteins
    IFN-γ ELIspot assay was performed with overlapping spike peptide pools from ( A ) vaccine strain and ( B ) <t>S1</t> <t>spike</t> <t>proteins</t> from vaccine strain or Omicron variant in VR21, VR26, and VR37 1–3 weeks after boost in A; in VR37 and VR97 1–3 weeks after boost in B; and in breakthrough VRs. IFN-γ spot-forming units (SFU) per million PBMCs are shown. Orange diamonds represent VR21, VR26, VR37, and VR97 at the breakthrough time point. Statistical comparisons were done using ordinary 1-way ANOVA (unpaired) and Holm-Šidák’s multiple comparison test, with a single pool variance used. * P =0.0332, ** P =0.0021.
    S1 Subunit Vaccine Strain Omicron Variant Spike Proteins, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s1 subunit vaccine strain omicron variant spike proteins/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    s1 subunit vaccine strain omicron variant spike proteins - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge"

    Article Title: SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge

    Journal: JCI Insight

    doi: 10.1172/jci.insight.159474

    IFN-γ ELIspot assay was performed with overlapping spike peptide pools from ( A ) vaccine strain and ( B ) S1 spike proteins from vaccine strain or Omicron variant in VR21, VR26, and VR37 1–3 weeks after boost in A; in VR37 and VR97 1–3 weeks after boost in B; and in breakthrough VRs. IFN-γ spot-forming units (SFU) per million PBMCs are shown. Orange diamonds represent VR21, VR26, VR37, and VR97 at the breakthrough time point. Statistical comparisons were done using ordinary 1-way ANOVA (unpaired) and Holm-Šidák’s multiple comparison test, with a single pool variance used. * P =0.0332, ** P =0.0021.
    Figure Legend Snippet: IFN-γ ELIspot assay was performed with overlapping spike peptide pools from ( A ) vaccine strain and ( B ) S1 spike proteins from vaccine strain or Omicron variant in VR21, VR26, and VR37 1–3 weeks after boost in A; in VR37 and VR97 1–3 weeks after boost in B; and in breakthrough VRs. IFN-γ spot-forming units (SFU) per million PBMCs are shown. Orange diamonds represent VR21, VR26, VR37, and VR97 at the breakthrough time point. Statistical comparisons were done using ordinary 1-way ANOVA (unpaired) and Holm-Šidák’s multiple comparison test, with a single pool variance used. * P =0.0332, ** P =0.0021.

    Techniques Used: Enzyme-linked Immunospot, Variant Assay, Comparison



    Similar Products

    s1 subunit vaccine strain omicron variant spike proteins  (GenScript corporation)
    90
    GenScript corporation s1 subunit vaccine strain omicron variant spike proteins
    IFN-γ ELIspot assay was performed with overlapping spike peptide pools from ( A ) vaccine strain and ( B ) <t>S1</t> <t>spike</t> <t>proteins</t> from vaccine strain or Omicron variant in VR21, VR26, and VR37 1–3 weeks after boost in A; in VR37 and VR97 1–3 weeks after boost in B; and in breakthrough VRs. IFN-γ spot-forming units (SFU) per million PBMCs are shown. Orange diamonds represent VR21, VR26, VR37, and VR97 at the breakthrough time point. Statistical comparisons were done using ordinary 1-way ANOVA (unpaired) and Holm-Šidák’s multiple comparison test, with a single pool variance used. * P =0.0332, ** P =0.0021.
    S1 Subunit Vaccine Strain Omicron Variant Spike Proteins, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s1 subunit vaccine strain omicron variant spike proteins/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    s1 subunit vaccine strain omicron variant spike proteins - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    IFN-γ ELIspot assay was performed with overlapping spike peptide pools from ( A ) vaccine strain and ( B ) S1 spike proteins from vaccine strain or Omicron variant in VR21, VR26, and VR37 1–3 weeks after boost in A; in VR37 and VR97 1–3 weeks after boost in B; and in breakthrough VRs. IFN-γ spot-forming units (SFU) per million PBMCs are shown. Orange diamonds represent VR21, VR26, VR37, and VR97 at the breakthrough time point. Statistical comparisons were done using ordinary 1-way ANOVA (unpaired) and Holm-Šidák’s multiple comparison test, with a single pool variance used. * P =0.0332, ** P =0.0021.

    Journal: JCI Insight

    Article Title: SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge

    doi: 10.1172/jci.insight.159474

    Figure Lengend Snippet: IFN-γ ELIspot assay was performed with overlapping spike peptide pools from ( A ) vaccine strain and ( B ) S1 spike proteins from vaccine strain or Omicron variant in VR21, VR26, and VR37 1–3 weeks after boost in A; in VR37 and VR97 1–3 weeks after boost in B; and in breakthrough VRs. IFN-γ spot-forming units (SFU) per million PBMCs are shown. Orange diamonds represent VR21, VR26, VR37, and VR97 at the breakthrough time point. Statistical comparisons were done using ordinary 1-way ANOVA (unpaired) and Holm-Šidák’s multiple comparison test, with a single pool variance used. * P =0.0332, ** P =0.0021.

    Article Snippet: The IFN-γ ELISpot assay was used to analyze T cell responses to SARS-CoV-2 spike and nucleocapsid peptide pools (BEI Resources) and the S1 subunit of the vaccine strain and Omicron variant spike proteins (Genscript Biotech Corporation).

    Techniques: Enzyme-linked Immunospot, Variant Assay, Comparison